Sort
50,496 grants matching “lung cancer”
Development of a novel pan-cancer CAR-T product against AML and Glioblastoma
$400,000David Soler · Kure. Ai, Inc. · R43 · FY2024 · CA
Rapid 3D Whole-Slide Digitization of Thick Cytopathology Slides with a Gigapixel Microscope
$400,000Mark Harfouche · Ramona Optics, Inc. · R44 · FY2020 · CA
Magnet for a 7T Small Animal MRI System
$400,000Thomas T Liu · University Of California, San Diego · S10 · FY2011 · RR
Developing a Novel Biologic Therapy to Eradicate Brain Cancer and Brain Metastasis
$400,000Donald Davidson · Creative Biotherapeutics, Llc · R43 · FY2024 · CA
N6-Methyl-2'-O-Methyladenosine Sequencing
$400,000Eric Ervin · Electronic Biosciences, Inc. · R43 · FY2020 · CA
CAREER: Lifesaving Robotic Tentacles
$400,000Robert J Webster · Vanderbilt University · · FY2011 · CSE
Alpha 5 nAChR is a Risk Factor within the Dopamine System for Nicotine Addiction
$400,000John A. Dani · University Of Pennsylvania · R01 · FY2017 · DA
First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy
$400,000Pan Zheng · Oncoimmune, Inc. · R44 · FY2020 · CA
Novel small-molecule therapeutics for malignant peripheral nerve sheath tumor
$400,000Tsung-Chieh Shih · Kibio Inc. · R43 · FY2022 · CA
Bioengineering 3-D Models for Organ-Specific Cancer Therapy in Lung and Breast
$400,000Mina J Bissell · University Of Calif-Lawrenc Berkeley Lab · U54 · FY2006 · CA
Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation
$400,000Bryce Beverlin II · Quench Medical, Inc. · R43 · FY2020 · CA
Regulation and function of nonlymphoid organ CD103 dendritic cells
$400,000Stephanie S Watowich · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · AI
Collaborative Research: Heterogeneous Cancer Cell Mechanics Differentially Drives Mechanosensing and Migration
$400,000Adam J Engler · University Of California-San Diego · · FY2018 · ENG
CDP - Career Development Program
$400,000Eric B. Haura · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2012 · CA
High-throughput Label-free Biosensor Platform for Rapid Detection of Antigen-specific T Cells with Single Cell Resolution
$400,000Farshid Ghasemi · Weddell Technologies Llc · R43 · FY2021 · CA
Development of Deep Mutational Scanning with Duplex Sequencing (DMS-DS) for anti-cancer drug evaluation and administration
$400,000Joshua Reynolds · Atlas Biologics, Llc · R42 · FY2024 · CA
MWA verification system for improved confidence in treatment outcomes
$400,000Austin Pfannenstiel · Precision Microwave, Inc. · R43 · FY2022 · CA
Targeting glioblastoma with CM93, a novel EGFR inhibitor with exceptional brain penetration
$400,000Jean Zhao · Crimson Biopharm Inc · R41 · FY2023 · CA
Engineered TCR-T Cell Therapy Targeting Driver Mutations in NSCLC
$400,000Matthew James Spindler · Gigamune, Inc. · R43 · FY2021 · CA
P1 - E2F's impact on Therapeutic Efficacy
$400,000Doug Cress · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2012 · CA
Evaluation of lead FANA oligos targeting FOXP3, with and without anti-PD-1 mAb, as an approach for cancer immunotherapy
$400,000Veenu Aishwarya · Aum Lifetech, Inc. · R43 · FY2022 · CA
Washington University Molecular Imaging Center
$400,000Washington University · P50 · FY2002 · CA
Non-invasive detection of tumor NTRK gene fusions via rapid, efficient and low-cost extracellular vesicle isolation method
$400,000Hongzhang He · Captis Diagnostics · R43 · FY2023 · CA
Regulation and function of nonlymphoid organ CD103 dendritic cells
$400,000Stephanie S Watowich · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · AI
P3 - Antitumor Mechanisms of SRC Inhibitors in Lung Cancer
$400,000Eric B. Haura · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2012 · CA